Scientific work

Doç. Dr. Yakup İriağaç

51 publications. The source of the information is stated next to each publication.

Back to profile

  1. Radiotherapy improves outcomes in patients with NSCLC receiving nivolumab

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15805-w PMID 41749167 Open-access full textSource: ORCID

  2. Analysis of prognostic factors in metastatic colon cancer

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1803902 Open-access full textSource: ORCID

  3. The impact of exercise prehabilitation on upper extremity range of motions, functionality and quality of life in breast cancer survivors: a prospective clinical trial

    BMC Sports Science, Medicine and Rehabilitation, 2026

    DOI 10.1186/s13102-026-01534-x PMID 41612417 Open-access full textSource: ORCID

  4. Survival Impact of Adjuvant Chemoradiotherapy in Resected Pancreatic Cancer

    Namık Kemal Tıp Dergisi, 2025

    DOI 10.4274/nkmj.galenos.2025.81994 Open-access full textSource: OpenAlex

  5. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1639022 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  7. The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer

    Medicine, 2025

    DOI 10.1097/md.0000000000044743 PMID 41029123 1 citation (Europe PMC) Open-access full textSource: ORCID

  8. Prognostic Value of Estrogen Receptor Co-activator AIB1 in Metastatic Breast Cancer Patients Treated with a Combination of Ribociclib and Letrozole

    Bratislava Medical Journal, 2025

    DOI 10.1007/s44411-025-00237-y Open-access full textSource: ORCID

  9. Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?

    Revista da Associação Médica Brasileira, 2025

    DOI 10.1590/1806-9282.20250507 PMID 41124552 Open-access full textSource: ORCID

  10. Androgen Receptor: Clinical Importance in Breast Cancer Patients Receiving CDK 4/6 Inhibitor Treatment

    Medicina, 2025

    DOI 10.3390/medicina61081464 PMID 40870508 Open-access full textSource: ORCID

  11. Predictive Factors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing 177Lu-PSMA-617 Radioligand Treatment

    Journal of the College of Physicians and Surgeons Pakistan, 2025

    DOI 10.29271/jcpsp.2025.10.1261 PMID 41058281 Open-access full textSource: ORCID

  12. Spectrum of BRCA1 and BRCA2 Variants in Breast Cancer Cases: A Single-Center Experience

    DergiPark (Istanbul University), 2025

    Source: OpenAlex

  13. Melatonin enhances everolimus efficacy in breast cancer by suppressing mTOR pathway activation and promoting apoptosis and mitochondrial function

    BMC Pharmacology and Toxicology, 2025

    DOI 10.1186/s40360-025-00907-1 PMID 40355936 8 citations (OpenAlex) Open-access full textSource: OpenAlex

  14. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

    BMC Cancer, 2024

    DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  15. Nanotechnology in oncology: a mini review

    Revista da Associação Médica Brasileira, 2024

    DOI 10.1590/1806-9282.20241347 PMID 39630738 Open-access full textSource: ORCID

  16. Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience

    Medicina, 2024

    DOI 10.3390/medicina60050818 PMID 38793001 4 citations (Europe PMC) Open-access full textSource: ORCID

  17. Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2024

    DOI 10.29271/jcpsp.2024.01.37 PMID 38185958 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  18. POLAND'S SENDROMU VE MEME KANSERİ: VAKA TAKDİMİ VE LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ

    DergiPark (Istanbul University), 2024

    Open-access full textSource: OpenAlex

  19. Major and minor salivary gland cancers: A multicenter retrospective study

    Head & Neck, 2023

    DOI 10.1002/hed.27376 PMID 37084179 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  20. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  21. Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study

    Neoplasma, 2023

    DOI 10.4149/neo_2022_221004n984 PMID 36620878 Open-access full textSource: OpenAlex

  22. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1287 PMID 37133230 22 citations (Europe PMC) Open-access full textSource: OpenAlex

  23. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

    Medicine, 2023

    DOI 10.1097/md.0000000000035950 PMID 37960746 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  24. The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.59908 1 citation (OpenAlex) Open-access full textSource: ORCID

  25. Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

    Supportive Care in Cancer, 2023

    DOI 10.1007/s00520-023-07791-7 PMID 37162602 4 citations (Europe PMC) Source: ORCID

  26. Investigation of the Effect of Low-positive HER-2 on Neoadjuvant Chemotherapy Response in Hormone-positive Breast Cancer Patients

    Journal of Academic Research in Medicine, 2023

    DOI 10.4274/jarem.galenos.2023.30074 1 citation (OpenAlex) Open-access full textSource: ORCID

  27. A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy

    Revista da Associação Médica Brasileira, 2023

    DOI 10.1590/1806-9282.20221255 PMID 36921198 Open-access full textSource: ORCID

  28. Use of Complementary Therapy in Lung Cancer Patients Treated with Chemotherapy and its Effect on Survival: A Cross-sectional Study

    Medical Bulletin of Haseki, 2023

    DOI 10.4274/haseki.galenos.2023.8591 1 citation (OpenAlex) Open-access full textSource: ORCID

  29. A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic Therapy

    Journal of College of Physicians and Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.05.548 PMID 37190691 1 citation (Europe PMC) Open-access full textSource: ORCID

  30. Stresli Yasam Olaylarının Meme Kanseri Gelişimdeki Rolü

    DergiPark (Istanbul University), 2023

    Open-access full textSource: OpenAlex

  31. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

    Future Oncology, 2022

    DOI 10.2217/fon-2022-0083 PMID 35734870 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  32. Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer

    Bagcilar Medical Bulletin, 2022

    DOI 10.4274/bmb.galenos.2022.2021-09-098 Open-access full textSource: OpenAlex

  33. Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1276_21 PMID 37313913 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  34. Paraneoplastik Sendromlar

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1826 Open-access full textSource: ORCID

  35. Nadir Tümörler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2239 1 citation (OpenAlex) Source: ORCID

  36. Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study

    Iberoamerican Journal of Medicine, 2022

    DOI 10.53986/ibjm.2022.0033 1 citation (OpenAlex) Open-access full textSource: ORCID

  37. The influence of visual objects and music on anxiety levels of breast cancer patients scheduled to experience chemotherapy for the first time: a prospective randomized clinical study

    Supportive Care in Cancer, 2022

    DOI 10.1007/s00520-021-06778-6 PMID 35094139 3 citations (Europe PMC) Open-access full textSource: ORCID

  38. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer

    Journal of Geriatric Oncology, 2022

    DOI 10.1016/j.jgo.2022.03.004 PMID 35361561 18 citations (Europe PMC) Source: ORCID

  39. Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T-cell infiltration

    Wspolczesna Onkologia, 2022

    DOI 10.5114/wo.2022.113502 PMID 35506036 10 citations (Europe PMC) Open-access full textSource: ORCID

  40. Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with Chemotherapy

    Journal of College of Physicians And Surgeons Pakistan, 2022

    DOI 10.29271/jcpsp.2022.11.1420 PMID 36377008 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  41. Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer

    Bratislavské lekárske listy/Bratislava medical journal, 2022

    DOI 10.4149/bll_2022_063 PMID 35576541 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  42. Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5414 PMID 36326379 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  43. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1405_22 PMID 38554312 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  44. Malign Plevral Mezotelyoma

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2239.c17283 Source: OpenAlex

  45. Testiküler Tümörler ve Paraneoplastik Sendromlar

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1826.c17428 Source: OpenAlex

  46. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study

    Journal of Cancer Research and Clinical Oncology, 2021

    DOI 10.1007/s00432-021-03748-7 PMID 34331582 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  47. Effects of COVID-19 Pandemic on Diagnosis-treatment Process in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

    Namık Kemal Tıp Dergisi, 2021

    DOI 10.4274/nkmj.galenos.2021.69775 Open-access full textSource: ORCID

  48. The Influence of Visual Objects and Music on Anxiety Levels of Breast Cancer Patients Scheduled to Experience Chemotherapy for the First Time: A Prospective Randomized Clinical Study

    2021

    DOI 10.21203/rs.3.rs-1055951/v1 Open-access full textSource: ORCID

  49. Mindfulness Among Medical Oncology Doctors and Its Relation With Burnout: Turkish Oncology Group (TOG) Study

    JCO Oncology Practice, 2021

    DOI 10.1200/op.20.01037 PMID 33835862 2 citations (Europe PMC) Source: ORCID

  50. Yaygın evre küçük hücreli akciğer kanserinde lenfosit/monosit oranının prognostik önemi

    Ahi Evran Medical Journal, 2021

    DOI 10.46332/aemj.886928 Open-access full textSource: OpenAlex